Keyphrases
Stent
100%
Patient Outcomes
100%
Long-stay Patients
100%
Biodegradable Polymer Drug-eluting Stents
100%
Durable Polymer
60%
Biodegradable Polymers
40%
Non-inferiority
40%
Sirolimus-eluting Stent
40%
Clinically Significant
20%
Myocardial Infarction
20%
Pooled Analysis
20%
Clinical Efficacy
20%
Polymer-coated
20%
Lancet
20%
Randomized Trial
20%
Coronary Intervention
20%
Statistical Significance
20%
Clinical Benefit
20%
Risk Ratio
20%
Late Events
20%
Risk Difference
20%
Surrogate Endpoint
20%
Efficacy Study
20%
Generation Device
20%
Polymer Devices
20%
Patients with Coronary Artery Disease
20%
Drug-eluting Stent
20%
Stent Thrombosis
20%
Ongoing Clinical Trials
20%
Adjudication
20%
Early Generation
20%
Long-term Clinical Outcome
20%
Non-inferiority Trial
20%
Vascular Healing
20%
Myocardial Revascularization
20%
Polymeric Stent
20%
Preclinical Safety Studies
20%
Biodegradable Polymer Biolimus-eluting Stents
20%
Clinical Outcome Study
20%
Large Scale Trial
20%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Clinical Trial
50%
Safety Assessment
50%
Efficacy Study
50%
Noninferiority Trial
50%
Heart Infarction
50%
Coronary Artery Disease
50%
Stent Thrombosis
50%
Umirolimus
50%
Medicine and Dentistry
Drug-Eluting Stent
100%
Rapamycin
40%
Clinical Trial
20%
Coronary Artery Disease
20%
Myocardial Infarction
20%
Pooled Analysis
20%
Attributable Risk
20%
Safety Assessment
20%
Heart Muscle Revascularization
20%
Stent Thrombosis
20%
Noninferiority Trial
20%
Efficacy Study
20%
Umirolimus
20%
Engineering
Eluting Stent
100%
Durables
37%
Clinical Outcome
25%
Proof-of-Concept
12%
Endpoint
12%
Generation Device
12%
Scale Trial
12%
Randomized Trial
12%
Material Science
Biodegradable Polymer
100%
Composite Material
12%
Chemical Engineering
Biodegradable Polymer
100%